New directions in antiplatelet therapy.
Heart Diseases Institute, Hospital Universitari de Bellvitge-IDIBELL, University of Barcelona, L'Hospitalet de Llobregat, Barcelona, Spain.
José Luis
JL
Ferreiro
Dominick J
DJ
Angiolillo
D054058:Acute Coronary Syndrome / Q000097:blood / Q000188:drug therapy*; D015906:Angioplasty, Balloon, Coronary / Q000009:adverse effects*; D000818:Animals; D001792:Blood Platelets / Q000187:drug effects* / Q000378:metabolism; D023903:Coronary Restenosis / Q000097:blood / Q000209:etiology / Q000517:prevention & control*; D003328:Coronary Thrombosis / Q000097:blood / Q000209:etiology / Q000517:prevention & control*; D015507:Drugs, Investigational / Q000009:adverse effects / Q000627:therapeutic use*; D006470:Hemorrhage / Q000139:chemically induced; D006801:Humans; D010975:Platelet Aggregation Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*; D018570:Risk Assessment; D012307:Risk Factors; D016896:Treatment Outcome
D015507:Drugs, Investigational; D010975:Platelet Aggregation Inhibitors